Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 11,000 | 0 | 0 | 250 | 429 |
| Gross Profit | 11,000 | N/A | N/A | 250 | 429 |
| Operating Expenses | 84,943 | 129,687 | 108,140 | 96,690 | 30,528 |
| Operating Income | -73,943 | -129,687 | -108,140 | -96,440 | -30,099 |
| Interest Expense | 0 | 0 | 0 | 3 | 1,389 |
| Other Income | 4,167 | 6,225 | 1,658 | 1,041 | -4,365 |
| Pre-tax Income | -69,776 | -123,462 | -106,482 | -95,402 | -35,853 |
| Net Income Continuous | -69,776 | -123,462 | -106,482 | -95,402 | -35,853 |
| Net Income | $-69,776 | $-123,462 | $-106,482 | $-95,402 | $-35,853 |
| EPS Basic Total Ops | -1.44 | -2.58 | -2.74 | -2.76 | -3.19 |
| EPS Basic Continuous Ops | -1.44 | -2.58 | -2.74 | -2.76 | -4.25 |
| EPS Diluted Total Ops | -1.44 | -2.58 | -2.74 | -2.76 | -3.19 |
| EPS Diluted Continuous Ops | -1.44 | -2.58 | -2.74 | -2.76 | -4.25 |
| EPS Diluted Before Non-Recurring Items | -1.46 | -2.58 | -2.74 | -2.76 | N/A |
| EBITDA(a) | $-73,018 | $-128,466 | $-106,941 | $-95,110 | $-29,091 |